Author: United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category :
Languages : en
Pages : 340
Get Book
Book Description
Author: United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category :
Languages : en
Pages : 340
Get Book
Book Description
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 264
Get Book
Book Description
Author: United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category : Dimethyl sulfoxide
Languages : en
Pages : 108
Get Book
Book Description
Author: John Braithwaite
Publisher: Routledge
ISBN: 1135072892
Category : Social Science
Languages : en
Pages : 437
Get Book
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Author:
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 208
Get Book
Book Description
Author: Thomas A. Lindsley
Publisher:
ISBN:
Category :
Languages : en
Pages : 554
Get Book
Book Description
Author:
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 232
Get Book
Book Description
Author: Mickey C. Smith
Publisher: CRC Press
ISBN: 1000263657
Category : Business & Economics
Languages : en
Pages : 433
Get Book
Book Description
Pharmaceuticals constitute a relatively small share of the total Health Care expenditure in most developed economies, and yet they play a critical role in the ongoing debate over how best to advance, improve, and afford Health Care. Despite this, and perhaps because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, and support and condemnation. Unfortunately, many participants in the debate do not fully understand the complexities of the industry and its role in the overall Health Care system. The analytical tools of economics provide a strong foundation for a better understanding of the dynamics of the pharmaceutical industry, its contribution to Health and Health Care, and its dual and often conflicting priorities of affordability and innovation, as well as the various Private and Public Policy initiatives directed at the sector. Everyone is affected by Big Pharma and the products they produce. At the Drug store, the physician’s office, in front of the television, in everyday conversations, Drugs are a part of our lives. Society shapes our values toward Drugs and Drugs shape society. ("The Pill" and minor tranquilizers are good examples.) And, of course, the way Congress deliberates and Big Pharma responds has a huge impact on how Drugs affect our lives. This book is well-researched on the subject of the pharmaceutical industry, its struggles with Government, and its relationship to the consumer from the early twentieth century until the present. The Dynamic Tension between the three participants – Government, Big Pharma, and the People – is described and explained to lead to an understanding of the controversies that rage today. The author describes how the Government, its many investigatory efforts, and the ultimate legislative results affect the industry and the consequences of their activities are explored in light of their effects on other players, including the patients and consumers who rely on both Government and Big Pharma for their well-being and who find sometimes unexpected consequences while giving special attention to the attitudes, beliefs, and misadventures of less-than-optimal Drug use. Stakeholders are identified with physicians as a major focus, as well as describing the significance of prescriptions as social objects and the processes by which physicians make choices on behalf of their patients. The author ties it all together with how Big Pharma affects and is affected by each of these groups. The author utilizes his 50-plus years’ experience as an academic, practicing pharmacist, and Big Pharma employee to describe the scope of the pharmaceutical industry and how it affects us on a daily basis, concluding with an inside look at Big Pharma and how regulations, marketing, and the press have affected their business, both good and bad.
Author:
Publisher:
ISBN:
Category : Public administration
Languages : en
Pages : 1228
Get Book
Book Description